Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04886284Phase 2Recruiting
Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia
Staphylococcal SepsisStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis+1 more
PrincipalinvestigatorStart date: 2024-05-20

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Research Institute of the McGill University Health Centre

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Emily G McDonald, MD MSc

Research Institute of the McGill University Health Centre

Moderately Similar
4 trials

Shared therapeutic areas:

Staphylococcus Aureus EndocarditisStaphylococcus Aureus SepticemiaStaphylococcus Aureus Bacteremia+1 more

Worked with same sponsors:

Todd C. Lee MD MPH FIDSA
Collaborated on 1 trial
Similarity Score44%

Pablo Tebas, MD

University of Pennsylvania

Related
14 trials

Shared therapeutic areas:

Staphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis
Similarity Score15%

Anna Goodman

University College, London

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus BacteremiaStaphylococcus Aureus Septicemia
Similarity Score15%

Mark Rupp, M.D.

University of Nebraska

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Mical Paul, MD

Head of Infectious Diseases Unit, Rambam Health Care Campus, Haifa, Israel

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Leonard Weisman, MD

Baylor College of Medicine

Related
3 trials

Shared therapeutic areas:

Staphylococcal Sepsis
Similarity Score8%

Deborah Birx, MD

Armata Pharmaceuticals, Inc.

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Hong-Bin Kim, M.D, PhD

Seoul National University Bundang Hospital

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Wan Beom Park, M.D, PhD

Seoul National University Hospital

Related
1 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Jesús Rodríguez-Baño

Hospital Universitario Virgen Macarena

Related
2 trials

Shared therapeutic areas:

Staphylococcus Aureus Bacteremia
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04886284Phase 2PrincipalInvestigator

Combination Cefazolin With Ertapenem for Methicillin-susceptible Staphylococcus Aureus Bacteremia

Staphylococcal SepsisStaphylococcus Aureus BacteremiaStaphylococcus Aureus Endocarditis+1 more
Recruiting

All 1 trials loaded